Page last updated: 2024-12-05

pentrinitrol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pentrinitrol: coronary vasodilator agent; minor descriptor (75-85); on-line & Index Medicus search PROPYLENE GLYCOLS (75-85) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15353
CHEMBL ID466660
CHEBI ID135114
SCHEMBL ID122322
MeSH IDM0263008

Synonyms (37)

Synonym
4sl9hwa66p ,
1,3-propanediol, 2,2-bis((nitrooxy)methyl)-, 1-nitrate
unii-4sl9hwa66p
pentrinitrolum
2-hydroxymethyl-2-nitrooxymethylpropane-1,3-diyl dinitrate
C0052
1,3-dinitrato-2-nitratomethyl-2-hydroxymethylpropane
petrin
pet, trinitrate
pentaerythritol trinitrate
einecs 216-529-7
pentrinitrol [usan:inn]
pentrinitrolum [inn-latin]
w 2197
1,3-propanediol, 2,2-bis((nitrooxy)methyl)-, mononitrate (ester)
pentaerythrityl trinitrate
D05430
petrin (tn)
pentrinitrol (usan)
1607-17-6
w-2197 ,
pentrinitrol
CHEBI:135114
[2-(hydroxymethyl)-3-nitrooxy-2-(nitrooxymethyl)propyl] nitrate
CHEMBL466660
pentrinitrol [mi]
pentrinitrol [who-dd]
pentrinitrol [usan]
pentrinitrol [inn]
SCHEMBL122322
3-nitrooxy-2,2-bis(nitrooxymethyl)propan-1-ol
BRBAEHHXGZRCBK-UHFFFAOYSA-N
DTXSID10862712
1,3-propanediol, 2,2-bis[(nitrooxy)methyl]-, 1-nitrate
1-(2-chloro-ethyl)-4-(3-trifluoromethyl-phenyl)-piperazinedihydrochloride
Q2069313
AKOS040753458

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The relative bioavailability of the tablets as determined by means of the AUC of PE-di-N is 280-290%."( Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites.
Kuntze, U; Luckow, V; Michaelis, K; Stalleicken, D; Weber, W, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nitrate esterAny member of the class of nitrates resulting from the esterification of nitric acid with an alcohol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID352262Vasorelaxant activity in pig pulmonary artery by organ bath experiment2009Bioorganic & medicinal chemistry letters, Jun-01, Volume: 19, Issue:11
NO donors. Part 18: Bioactive metabolites of GTN and PETN--synthesis and vasorelaxant properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (20.00)18.7374
1990's5 (25.00)18.2507
2000's6 (30.00)29.6817
2010's5 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]